YG-1 Extract Improves Acute Pulmonary Inflammation by Inducing Bronchodilation and Inhibiting Inflammatory Cytokines

YG-1 extract used in this study is a mixture of <i>Lonicera japonica</i>, <i>Arctic Fructus</i>, and <i>Scutellariae Radix</i>. The present study was designed to investigate the effect of YG-1 extract on bronchodilatation (ex vivo) and acute bronchial and pulmonar...

Full description

Bibliographic Details
Main Authors: Hye-Yoom Kim, Jung-Joo Yoon, Dae-Sung Kim, Dae-Gill Kang, Ho-Sub Lee
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/13/10/3414
_version_ 1797513525535440896
author Hye-Yoom Kim
Jung-Joo Yoon
Dae-Sung Kim
Dae-Gill Kang
Ho-Sub Lee
author_facet Hye-Yoom Kim
Jung-Joo Yoon
Dae-Sung Kim
Dae-Gill Kang
Ho-Sub Lee
author_sort Hye-Yoom Kim
collection DOAJ
description YG-1 extract used in this study is a mixture of <i>Lonicera japonica</i>, <i>Arctic Fructus</i>, and <i>Scutellariae Radix</i>. The present study was designed to investigate the effect of YG-1 extract on bronchodilatation (ex vivo) and acute bronchial and pulmonary inflammation relief (in vivo). Ex vivo: The bronchodilation reaction was confirmed by treatment with YG-1 concentration-accumulation (0.01, 0.03, 0.1, 0.3, and 1 mg/mL) in the bronchial tissue ring pre-contracted by acetylcholine (10 μM). As a result, YG-1 extract is considered to affect bronchodilation by increased cyclic adenosine monophosphate, cAMP) levels through the β2-adrenergic receptor. In vivo: experiments were performed in C57BL/6 mice were divided into the following groups: control group; PM2.5 (fine particulate matter)-exposed group (PM2.5, 200 μg/kg/mL saline); and PM2.5-exposed + YG-1 extract (200 mg/kg/day) group. The PM2.5 (200 μg/kg/mL saline) was exposed for 1 h for 5 days using an ultrasonic nebulizer aerosol chamber to instill fine dust in the bronchi and lungs, thereby inducing acute lung and bronchial inflammation. From two days before PM2.5 exposure, YG-1 extract (200 mg/kg/day) was administered orally for 7 days. The PM2.5 exposure was involved in airway remodeling and inflammation, suggesting that YG-1 treatment improves acute bronchial and pulmonary inflammation by inhibiting the inflammatory cytokines (NLRP3/caspase-1 pathway). The application of YG-1 extract with broncho-dilating effect to acute bronchial and pulmonary inflammation animal models has great significance in developing therapeutic agents for respiratory diseases. Therefore, these results can provide essential data for the development of novel respiratory symptom relievers. Our study provides strong evidence that YG-1 extracts reduce the prevalence of respiratory symptoms and the incidence of non-specific lung diseases and improve bronchial and lung function.
first_indexed 2024-03-10T06:17:48Z
format Article
id doaj.art-013771c95dba4f09806111843798c522
institution Directory Open Access Journal
issn 2072-6643
language English
last_indexed 2024-03-10T06:17:48Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series Nutrients
spelling doaj.art-013771c95dba4f09806111843798c5222023-11-22T19:28:11ZengMDPI AGNutrients2072-66432021-09-011310341410.3390/nu13103414YG-1 Extract Improves Acute Pulmonary Inflammation by Inducing Bronchodilation and Inhibiting Inflammatory CytokinesHye-Yoom Kim0Jung-Joo Yoon1Dae-Sung Kim2Dae-Gill Kang3Ho-Sub Lee4Hanbang Cardio-Renal Research Center & Professional Graduate School of Oriental Medicine, Wonkwang University, Iksan 54538, KoreaHanbang Cardio-Renal Research Center & Professional Graduate School of Oriental Medicine, Wonkwang University, Iksan 54538, KoreaHanpoong Pharm and Foods Co., Ltd., Wanju 55316, KoreaHanbang Cardio-Renal Research Center & Professional Graduate School of Oriental Medicine, Wonkwang University, Iksan 54538, KoreaHanbang Cardio-Renal Research Center & Professional Graduate School of Oriental Medicine, Wonkwang University, Iksan 54538, KoreaYG-1 extract used in this study is a mixture of <i>Lonicera japonica</i>, <i>Arctic Fructus</i>, and <i>Scutellariae Radix</i>. The present study was designed to investigate the effect of YG-1 extract on bronchodilatation (ex vivo) and acute bronchial and pulmonary inflammation relief (in vivo). Ex vivo: The bronchodilation reaction was confirmed by treatment with YG-1 concentration-accumulation (0.01, 0.03, 0.1, 0.3, and 1 mg/mL) in the bronchial tissue ring pre-contracted by acetylcholine (10 μM). As a result, YG-1 extract is considered to affect bronchodilation by increased cyclic adenosine monophosphate, cAMP) levels through the β2-adrenergic receptor. In vivo: experiments were performed in C57BL/6 mice were divided into the following groups: control group; PM2.5 (fine particulate matter)-exposed group (PM2.5, 200 μg/kg/mL saline); and PM2.5-exposed + YG-1 extract (200 mg/kg/day) group. The PM2.5 (200 μg/kg/mL saline) was exposed for 1 h for 5 days using an ultrasonic nebulizer aerosol chamber to instill fine dust in the bronchi and lungs, thereby inducing acute lung and bronchial inflammation. From two days before PM2.5 exposure, YG-1 extract (200 mg/kg/day) was administered orally for 7 days. The PM2.5 exposure was involved in airway remodeling and inflammation, suggesting that YG-1 treatment improves acute bronchial and pulmonary inflammation by inhibiting the inflammatory cytokines (NLRP3/caspase-1 pathway). The application of YG-1 extract with broncho-dilating effect to acute bronchial and pulmonary inflammation animal models has great significance in developing therapeutic agents for respiratory diseases. Therefore, these results can provide essential data for the development of novel respiratory symptom relievers. Our study provides strong evidence that YG-1 extracts reduce the prevalence of respiratory symptoms and the incidence of non-specific lung diseases and improve bronchial and lung function.https://www.mdpi.com/2072-6643/13/10/3414YG-1 extractbronchodilationfine particulate matter (PM2.5)acute lung injuryairway inflammation
spellingShingle Hye-Yoom Kim
Jung-Joo Yoon
Dae-Sung Kim
Dae-Gill Kang
Ho-Sub Lee
YG-1 Extract Improves Acute Pulmonary Inflammation by Inducing Bronchodilation and Inhibiting Inflammatory Cytokines
Nutrients
YG-1 extract
bronchodilation
fine particulate matter (PM2.5)
acute lung injury
airway inflammation
title YG-1 Extract Improves Acute Pulmonary Inflammation by Inducing Bronchodilation and Inhibiting Inflammatory Cytokines
title_full YG-1 Extract Improves Acute Pulmonary Inflammation by Inducing Bronchodilation and Inhibiting Inflammatory Cytokines
title_fullStr YG-1 Extract Improves Acute Pulmonary Inflammation by Inducing Bronchodilation and Inhibiting Inflammatory Cytokines
title_full_unstemmed YG-1 Extract Improves Acute Pulmonary Inflammation by Inducing Bronchodilation and Inhibiting Inflammatory Cytokines
title_short YG-1 Extract Improves Acute Pulmonary Inflammation by Inducing Bronchodilation and Inhibiting Inflammatory Cytokines
title_sort yg 1 extract improves acute pulmonary inflammation by inducing bronchodilation and inhibiting inflammatory cytokines
topic YG-1 extract
bronchodilation
fine particulate matter (PM2.5)
acute lung injury
airway inflammation
url https://www.mdpi.com/2072-6643/13/10/3414
work_keys_str_mv AT hyeyoomkim yg1extractimprovesacutepulmonaryinflammationbyinducingbronchodilationandinhibitinginflammatorycytokines
AT jungjooyoon yg1extractimprovesacutepulmonaryinflammationbyinducingbronchodilationandinhibitinginflammatorycytokines
AT daesungkim yg1extractimprovesacutepulmonaryinflammationbyinducingbronchodilationandinhibitinginflammatorycytokines
AT daegillkang yg1extractimprovesacutepulmonaryinflammationbyinducingbronchodilationandinhibitinginflammatorycytokines
AT hosublee yg1extractimprovesacutepulmonaryinflammationbyinducingbronchodilationandinhibitinginflammatorycytokines